
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Koate DVI
Therapeutic Area : Genetic Disease
Study Phase : Approved FDF
Sponsor : WuXi Biologics
Deal Size : Undisclosed
Deal Type : Acquisition
WuXi Biologics and Bayer enter into acquisition agreement
Details : First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities. WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Undisclosed
January 16, 2020
Lead Product(s) : Koate DVI
Therapeutic Area : Genetic Disease
Highest Development Status : Approved FDF
Sponsor : WuXi Biologics
Deal Size : Undisclosed
Deal Type : Acquisition
